全文获取类型
收费全文 | 1838013篇 |
免费 | 138106篇 |
国内免费 | 3057篇 |
专业分类
耳鼻咽喉 | 26084篇 |
儿科学 | 62524篇 |
妇产科学 | 49242篇 |
基础医学 | 269357篇 |
口腔科学 | 50412篇 |
临床医学 | 163218篇 |
内科学 | 362086篇 |
皮肤病学 | 40970篇 |
神经病学 | 139687篇 |
特种医学 | 71583篇 |
外国民族医学 | 718篇 |
外科学 | 278965篇 |
综合类 | 39209篇 |
现状与发展 | 3篇 |
一般理论 | 515篇 |
预防医学 | 137580篇 |
眼科学 | 41530篇 |
药学 | 137959篇 |
5篇 | |
中国医学 | 4394篇 |
肿瘤学 | 103135篇 |
出版年
2018年 | 19334篇 |
2017年 | 14723篇 |
2016年 | 16258篇 |
2015年 | 18216篇 |
2014年 | 25310篇 |
2013年 | 38553篇 |
2012年 | 52218篇 |
2011年 | 55184篇 |
2010年 | 32860篇 |
2009年 | 31135篇 |
2008年 | 52309篇 |
2007年 | 56019篇 |
2006年 | 56605篇 |
2005年 | 54443篇 |
2004年 | 53196篇 |
2003年 | 51268篇 |
2002年 | 50184篇 |
2001年 | 91559篇 |
2000年 | 94421篇 |
1999年 | 79544篇 |
1998年 | 21275篇 |
1997年 | 18919篇 |
1996年 | 19473篇 |
1995年 | 18465篇 |
1994年 | 17373篇 |
1993年 | 16066篇 |
1992年 | 62418篇 |
1991年 | 61318篇 |
1990年 | 59709篇 |
1989年 | 57592篇 |
1988年 | 52838篇 |
1987年 | 51677篇 |
1986年 | 48402篇 |
1985年 | 46117篇 |
1984年 | 34361篇 |
1983年 | 28927篇 |
1982年 | 16503篇 |
1981年 | 14905篇 |
1979年 | 30762篇 |
1978年 | 21446篇 |
1977年 | 18156篇 |
1976年 | 17132篇 |
1975年 | 18613篇 |
1974年 | 21750篇 |
1973年 | 20866篇 |
1972年 | 19372篇 |
1971年 | 17777篇 |
1970年 | 16913篇 |
1969年 | 15381篇 |
1968年 | 14108篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
Bielik Peter Bonczek Ondřej Krejčí Přemysl Zeman Tomáš Izakovičová-Hollá Lydie Šoukalová Jana Vaněk Jiří Vojtěšek Bořivoj Lochman Jan Balcar Vladimir J. Šerý Omar 《Clinical oral investigations》2022,26(12):7045-7055
Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of... 相似文献
152.
Chumakov E. M. Petrova N. N. Limankin O. V. Ashenbrenner Yu. V. 《Neuroscience and behavioral physiology》2022,52(1):45-51
Neuroscience and Behavioral Physiology - Objective. To determine the frequency, structure, and severity of cognitive impairments in patients with bipolar affective disorder (BAD) in remission.... 相似文献
153.
154.
Accurate diagnosis and recognition of predisposing factors has been shown to be challenging in lower limb cellulitis (LLC). Assessment of 1746 consecutive patients with cellulitis presenting to a UK university hospital showed increasing overdiagnosis, with only 31.9% of patients referred during the period 2015–2018 having the diagnosis of LLC confirmed. Recognition of at least one predisposing factor increased from 61% to 89% following introduction of more specific screening questions. This identified a need for better primary care dermatology education and the benefit of a proforma with specific screening questions for reversible predisposing factors for LLC. 相似文献
155.
Sania Amr Magdy Garas Dina N. K. Boulos Doa’a A. Saleh Irene A. Jillson Christopher A. Loffredo 《Journal of substance use》2019,24(3):341-345
Background: Egyptian street youth use substances including tobacco, illicit drugs, and pharmaceutical drugs. To understand the circumstances, including adverse childhood experiences, that place adolescents at risk for engaging in substance use, we conducted in-depth interviews among a sample of Egyptian street children. Methods: From youth residing at or attending Caritas, a non-profit organization, which provides shelter and education to street youth, seven girls and twelve boys, aged 12–18 years, participated in open-ended, in-depth interviews. Results: Eight out of the 19 participants reported family history (early exposure) to substance use; and seven of them were initiated by either a family member (sibling), friend or coworker. Most of the participants reported a history of conflict with or abuse (verbal or physical) by their parents or siblings, or stressful situations at home; they used substance(s) to alleviate their stress. Few attended school, and some were forced to work and help their family. Conclusions: Among Egyptian youth, adverse childhood experiences, such as poverty, child abuse, and family substance use, challenge somewhat susceptible youths and lead them to the path of substance use and addiction. Prevention intervention should be multifaceted, culturally adaptable, and primarily targeting the social environment during childhood. 相似文献
156.
157.
T.-Y. Huang Y.-J. Hsia M.-Y. Sung Y.-T. Wu P.-C. Hsu 《International journal of oral and maxillofacial surgery》2021,50(8):1100-1106
Zygomatic implant treatment is widely applied for severe maxillary atrophy to help rehabilitate the maxillary dentition. This retrospective study was performed to evaluate the actual radiographic bone–implant contact (rBIC) lengths of zygomatic implants. The records of 28 patients who underwent zygomatic implant surgery and subsequent follow-up examinations between August 2013 and September 2018 in the Department of Oral and Maxillofacial Surgery, Taipei Tzu Chi Hospital were reviewed. The surgeries were performed by a single surgeon using the same treatment protocol. All patients had a computed tomography scan at 1 year after the surgery. Using three-dimensional imaging software, an investigator measured the rBIC lengths of 66 implants and documented their clinical status. The implant survival rate was 100%. The mean rBIC length was significantly longer in male patients than in female patients (20.80 ± 5.88 mm versus 17.79 ± 6.34 mm; P = 0.028). The mean rBIC length of double zygomatic implants was significantly longer when compared to that of single implants (21.11 ± 6.23 mm versus 17.75 ± 5.85 mm; P = 0.027). This article is novel in reporting the exact rBIC lengths of zygomatic implants in a clinical setting. The results showed that zygomatic implants are a viable treatment modality for full-mouth rehabilitation. 相似文献
158.
Conan MacDougall Theora Canonica Chris Keh Binh An P. Phan Janice Louie 《Pharmacotherapy》2022,42(4):343-361
Rifamycins (rifampin, rifabutin, and rifapentine) play an essential role in the treatment of mycobacterial and some nonmycobacterial infections. They also induce the activity of various drug transporting and metabolizing enzymes, which can impact the concentrations and efficacy of substrates. Many anticoagulant and antiplatelet (AC/AP) agents are substrates of these enzymes and have narrow therapeutic indices, leading to risks of thrombosis or bleeding when coadministered with rifamycins. The objective of this systematic review was to evaluate the effects on AC/AP pharmacokinetics, laboratory markers, and clinical safety and efficacy of combined use with rifamycins. A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidance was performed. The PubMed, Embase, and Web of Science databases were queried for English-language reports on combination use of rifamycins and AC/AP agents from database inception through August 2021. The 29 studies identified examined warfarin (n = 17), direct oral anticoagulants (DOACs) (n = 8), and antiplatelet agents (n = 4) combined with rifampin (n = 28) or rifabutin (n = 1). Eleven studies were case reports or small case series; 14 reported on pharmacokinetic or laboratory markers in healthy volunteers. Rifampin-warfarin combinations led to reductions in warfarin area under the curve (AUC) of 15%–74%, with variability by warfarin isomer and study. Warfarin dose increases of up to 3–5 times prerifampin doses were required to maintain coagulation parameters in the therapeutic range. DOAC AUCs were decreased by 20%–67%, with variability by individual agent and with rifampin versus rifabutin. The active metabolite of clopidogrel increased substantially with rifampin coadministration, whereas prasugrel was largely unaffected and ticagrelor saw decreases. Our review suggests most combinations of AC/AP agents and rifampin are problematic. Further studies are required to determine whether rifabutin or rifapentine could be safe alternatives for coadministration with AC/AP drugs. 相似文献
159.